Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to estimate the incidence of spontaneous and provoked recurrent VTE
and the bleeding events during a 10-year follow-up in subjects experiencing a first VTE
stratified according to % AT levels and to treatment schedule (long-term vs 6-12 months oral
anticoagulation+transient prophylaxis during high risk periods)